Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index

Sun Pharmaceutical Industries Ltd. has been included in the 2026 S&P Dow Jones Best-in-Class World Index, a globally respected benchmark that recognizes companies demonstrating strong leadership in sustainable performance.

The Dow Jones Best-in-Class Indices methodology identifies companies that lead their industries in addressing material sustainability issues and set global benchmarks for corporate sustainability performance. Based on the S&P Global Broad Market Index, nearly 2,500 of the world's largest companies were identified by S&P Global. Among them, around 317 companies worldwide qualified, including 25 from India, for inclusion in the 2026 DJBIC Index, making this recognition especially significant for us.

Kirti Ganorkar, Managing Director, Sun Pharma said, "This recognition is a testament to our continued commitment to responsible business practices and sustainable growth. At Sun Pharma, sustainability is embedded in the way we think, operate, and create value. It guides our purpose, shapes our actions, and remains central to our long-term strategy. Together with our people, we will continue driving meaningful impact through responsible innovation, climate-conscious operations, strong governance, and inclusive growth, while building a more sustainable future for generations to come".

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1863.45 as compared to the previous close of Rs. 1837.15. The total number of shares traded during the day was 38778 in over 2840 trades.

The stock hit an intraday high of Rs. 1865.40 and intraday low of 1834.20. The net turnover during the day was Rs. 71850063.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036